Maynard Ryan D - Insider Transactions
Insider Type
individual
Companies
2
Average
504,454
Total Txns
3
Long-Term
Annual Transaction Insights
Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
---|---|---|---|---|---|---|
2023 | 0 | 1 | -1 | 0.00 | 2,908.64 | -2,908.64 |
2024 | 0 | 2 | -2 | 0.00 | 1,006,000.00 | -1,006,000.00 |
Total: | 0 | 3 | 3 | 0.00 | 1,008,908.64 | -1,008,908.64 |
Transactions
Company | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Iovance Biotherapeutics, Inc. Common Stock US4622601007 |
10.06 USD |
50,000 Sold |
503,000 USD |
12/11/2024 | 12/11/2024 |
Iovance Biotherapeutics, Inc. Common Stock US4622601007 |
10.06 USD |
50,000 Sold |
503,000 USD |
12/11/2024 | 12/11/2024 |
Cara Therapeutics, Inc. Common Stock US1407551092 |
0.53 USD |
5,488 Sold |
2,909 USD |
08/02/2024 | 08/02/2023 |